Symbols / IDXG $2.00 -2.25% Interpace Biosciences, Inc.

Healthcare • Diagnostics & Research • United States • PNK
IDXG Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test for the diagnosis of pancreaticobiliary cancers using its proprietary PathFinderTG platform; PanDNA, a molecular only version of PancraGEN; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. The company also provides ThyraMIR v2, which assesses thyroid nodules for malignancy risk using a proprietary microRNA gene expression classifier; and RespriDx, a genomic test that enables physicians to differentiate metastatic or recurrent lung cancer. It primarily serves physicians, cancer centers, clinics, laboratories, pathology groups, and hospitals. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.

Fundamentals
Scroll to Statements
Market Cap 55.40M Enterprise Value 54.01M Income 24.98M Sales 38.73M Book/sh 4.93 Cash/sh 0.09
Dividend Yield — Payout 0.00% Employees 102 IPO — P/E 2.22 Forward P/E -13.33
PEG 0.36 P/S 1.43 P/B 0.41 P/C — EV/EBITDA 10.37 EV/Sales 1.40
Quick Ratio 1.60 Current Ratio 1.94 Debt/Eq 5.29 LT Debt/Eq — EPS (ttm) 0.90 EPS next Y -0.15
EPS Growth 153.90% Revenue Growth -25.70% Earnings 2022-11-14 ROA 12.30% ROE 248.03% ROIC —
Gross Margin 62.31% Oper. Margin 24.69% Profit Margin 63.46% Shs Outstand 27.70M Shs Float 3.47M Short Float 1.18%
Short Ratio 0.19 Short Interest — 52W High 2.40 52W Low 0.44 Beta 0.97 Avg Volume 6.18K
Volume 100.00 Target Price — Recom None Prev Close $2.05 Price $2.00 Change -2.25%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$2.00
Latest analyst target
3. DCF / Fair value
$3.31
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.00
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2021-11-17 down HC Wainwright & Co. Buy → Neutral —
2021-04-09 main HC Wainwright & Co. — → Buy $9
2021-01-25 main HC Wainwright & Co. — → Buy $6
2020-10-22 main HC Wainwright & Co. — → Buy $10
2020-06-26 main HC Wainwright & Co. — → Buy $11
2020-04-23 main HC Wainwright & Co. — → Buy $12
2020-04-15 init Janney Montgomery Scott — → Buy —
2020-01-16 main Oppenheimer — → Outperform $17
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-20 AMPERSAND 2018, L.P. Beneficial Owner of more than 10% of a Class of Security — 13,861,386 $2.02 $28,000,000
2026-01-20 1315 CAPITAL II, LP Beneficial Owner of more than 10% of a Class of Security — 9,405,941 $2.02 $19,000,001
2024-11-29 MCCARTHY CHRISTOPHER Chief Financial Officer — 38,475 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
38.73
-17.47%
46.93
+17.21%
40.04
+25.75%
31.84
Operating Revenue
38.73
-17.47%
46.93
+17.21%
40.04
+25.75%
31.84
Cost Of Revenue
14.60
-14.13%
17.00
+13.49%
14.98
+10.09%
13.61
Reconciled Cost Of Revenue
14.60
-14.13%
17.00
+19.39%
14.24
+25.19%
11.38
Gross Profit
24.13
-19.37%
29.93
+19.43%
25.06
+37.44%
18.23
Operating Expense
20.05
-8.12%
21.82
+3.43%
21.09
-4.43%
22.07
Research And Development
0.64
-5.03%
0.68
+6.29%
0.64
-9.53%
0.70
Selling General And Administration
19.40
-8.22%
21.14
+7.88%
19.60
-2.50%
20.10
Selling And Marketing Expense
9.92
-14.85%
11.65
+13.90%
10.23
+12.14%
9.12
General And Administrative Expense
9.48
-0.06%
9.49
+1.31%
9.36
-14.67%
10.97
Other Gand A
9.48
-0.06%
9.49
+1.31%
9.36
-14.67%
10.97
Total Expenses
34.64
-10.75%
38.82
+7.61%
36.07
+1.11%
35.68
Operating Income
4.08
-49.63%
8.11
+104.59%
3.96
+203.20%
-3.84
Total Operating Income As Reported
4.08
-49.63%
8.11
+104.95%
3.96
+209.37%
-3.62
EBITDA
4.76
-43.01%
8.36
+70.90%
4.89
+468.78%
-1.33
Normalized EBITDA
4.76
-43.01%
8.36
+70.66%
4.90
+416.14%
-1.55
Reconciled Depreciation
0.82
+9.76%
0.75
-53.28%
1.60
-54.28%
3.50
EBIT
3.94
-48.19%
7.61
+131.35%
3.29
+168.12%
-4.83
Total Unusual Items
—
0.00
+100.00%
-0.01
-103.14%
0.22
Total Unusual Items Excluding Goodwill
—
0.00
+100.00%
-0.01
-103.14%
0.22
Special Income Charges
—
0.00
+100.00%
-0.01
-103.14%
0.22
Restructuring And Mergern Acquisition
—
0.00
-100.00%
0.01
+103.14%
-0.22
Net Income
24.57
+266.68%
6.70
+242.99%
1.95
+108.90%
-21.96
Pretax Income
3.77
-45.70%
6.95
+204.69%
2.28
+139.08%
-5.84
Net Non Operating Interest Income Expense
-0.17
+74.51%
-0.66
+34.62%
-1.01
+0.00%
-1.01
Interest Expense Non Operating
0.17
-74.51%
0.66
-34.62%
1.01
+0.00%
1.01
Net Interest Income
-0.17
+74.51%
-0.66
+34.62%
-1.01
+0.00%
-1.01
Interest Expense
0.17
-74.51%
0.66
-34.62%
1.01
+0.00%
1.01
Other Income Expense
-0.14
+71.54%
-0.50
+25.96%
-0.67
+31.78%
-0.99
Other Non Operating Income Expenses
-0.14
+71.54%
-0.50
+25.19%
-0.67
+44.92%
-1.21
Tax Provision
-21.21
-530350.00%
0.00
-76.47%
0.02
-41.38%
0.03
Tax Rate For Calcs
0.00
+36358.33%
0.00
-91.77%
0.00
-96.67%
0.00
Tax Effect Of Unusual Items
0.00
0.00
+100.00%
-0.00
-100.10%
0.05
Net Income Including Noncontrolling Interests
24.57
+266.68%
6.70
+242.99%
1.95
+108.90%
-21.96
Net Income From Continuing Operation Net Minority Interest
24.98
+259.69%
6.95
+206.80%
2.26
+138.60%
-5.87
Net Income From Continuing And Discontinued Operation
24.57
+266.68%
6.70
+242.99%
1.95
+108.90%
-21.96
Net Income Continuous Operations
24.98
+259.69%
6.95
+206.80%
2.26
+138.60%
-5.87
Net Income Discontinuous Operations
-0.41
-67.62%
-0.24
+21.29%
-0.31
+98.07%
-16.09
Normalized Income
24.98
+259.69%
6.95
+205.86%
2.27
+137.59%
-6.04
Net Income Common Stockholders
24.57
+293.96%
6.24
+219.24%
1.95
+108.90%
-21.96
Otherunder Preferred Stock Dividend
—
—
—
—
Diluted EPS
0.89
+122.50%
0.40
+122.22%
0.18
+103.47%
-5.18
Basic EPS
5.55
+290.85%
1.42
+647.37%
0.19
+103.67%
-5.18
Basic Average Shares
4.42
+0.84%
4.39
+1.62%
4.32
+1.86%
4.24
Diluted Average Shares
27.70
+76.02%
15.73
+260.54%
4.36
+2.97%
4.24
Diluted NI Availto Com Stockholders
24.57
+293.96%
6.24
+219.24%
1.95
+108.90%
-21.96
Amortization
—
0.00
-100.00%
0.86
-32.20%
1.27
Amortization Of Intangibles Income Statement
—
0.00
-100.00%
0.86
-32.20%
1.27
Depreciation Amortization Depletion Income Statement
—
0.00
-100.00%
0.86
-32.20%
1.27
Depreciation And Amortization In Income Statement
—
0.00
-100.00%
0.86
-32.20%
1.27
Preferred Stock Dividends
—
0.46
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
33.84
+128.76%
14.79
+12.78%
13.12
-17.92%
15.98
Current Assets
9.90
-15.91%
11.77
+13.02%
10.42
-14.29%
12.15
Cash Cash Equivalents And Short Term Investments
2.50
+71.46%
1.46
-58.23%
3.50
-27.55%
4.83
Cash And Cash Equivalents
2.50
+71.46%
1.46
-58.23%
3.50
-27.55%
4.83
Receivables
5.65
-33.88%
8.54
+68.26%
5.08
+0.91%
5.03
Accounts Receivable
5.65
-33.88%
8.54
+68.26%
5.08
+0.91%
5.03
Gross Accounts Receivable
—
—
—
5.03
Allowance For Doubtful Accounts Receivable
—
—
—
0.00
Inventory
1.11
-8.01%
1.21
-1.30%
1.23
+0.25%
1.22
Raw Materials
1.11
-8.01%
1.21
-1.30%
1.23
+0.25%
1.22
Prepaid Assets
0.63
+18.13%
0.54
-9.32%
0.59
+51.28%
0.39
Restricted Cash
—
—
0.00
-100.00%
0.50
Assets Held For Sale Current
—
—
—
0.00
Other Current Assets
—
0.02
-8.33%
0.02
-86.67%
0.18
Total Non Current Assets
23.94
+692.91%
3.02
+11.86%
2.70
-29.44%
3.83
Net PPE
2.64
-11.23%
2.97
+12.06%
2.65
-9.08%
2.92
Gross PPE
5.91
+1.56%
5.82
+11.95%
5.20
-1.89%
5.30
Accumulated Depreciation
-3.27
-14.94%
-2.85
-11.83%
-2.54
-6.94%
-2.38
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
4.21
+13.08%
3.72
+21.47%
3.06
+14.20%
2.68
Other Properties
1.22
-24.55%
1.61
-13.47%
1.86
-23.58%
2.44
Leases
0.48
+0.00%
0.48
+79.55%
0.27
+53.71%
0.17
Goodwill And Other Intangible Assets
—
—
0.00
-100.00%
0.86
Goodwill
—
—
—
—
Other Intangible Assets
—
—
—
0.86
Non Current Deferred Assets
21.25
0.00
—
—
Non Current Deferred Taxes Assets
21.25
0.00
—
—
Other Non Current Assets
0.04
-2.22%
0.04
+0.00%
0.04
+0.00%
0.04
Total Liabilities Net Minority Interest
11.48
-32.53%
17.01
-75.23%
68.66
-13.15%
79.05
Current Liabilities
5.10
-51.93%
10.62
-7.18%
11.44
-19.93%
14.28
Payables And Accrued Expenses
4.01
-24.04%
5.28
-0.32%
5.30
-48.79%
10.35
Payables
1.28
-33.42%
1.92
+6.43%
1.80
+37.58%
1.31
Accounts Payable
0.98
-40.75%
1.66
+7.45%
1.54
+47.05%
1.05
Current Accrued Expenses
2.73
-18.68%
3.36
-3.81%
3.49
-61.33%
9.04
Total Tax Payable
0.30
+12.98%
0.26
+0.38%
0.26
-0.38%
0.26
Current Debt And Capital Lease Obligation
0.43
-90.78%
4.67
-14.68%
5.48
+77.94%
3.08
Current Debt
—
4.29
-15.88%
5.10
+104.00%
2.50
Other Current Borrowings
—
4.29
-15.88%
5.10
+104.00%
2.50
Current Capital Lease Obligation
0.43
+12.53%
0.38
+1.59%
0.38
-34.78%
0.58
Current Deferred Liabilities
—
—
—
—
Current Deferred Revenue
—
—
—
—
Other Current Liabilities
0.66
+0.00%
0.66
+0.00%
0.66
-23.08%
0.86
Total Non Current Liabilities Net Minority Interest
6.37
-0.33%
6.39
-88.83%
57.22
-11.66%
64.77
Liabilities Heldfor Sale Non Current
—
—
—
0.00
Long Term Debt And Capital Lease Obligation
0.75
-36.43%
1.18
-79.30%
5.71
-56.08%
13.01
Long Term Debt
—
—
4.24
-62.00%
11.16
Long Term Capital Lease Obligation
0.75
-36.43%
1.18
-19.63%
1.47
-20.35%
1.85
Non Current Deferred Liabilities
—
—
—
—
Non Current Deferred Revenue
—
—
—
—
Other Non Current Liabilities
5.62
+7.87%
5.21
+4.89%
4.97
-4.81%
5.22
Preferred Securities Outside Stock Equity
—
0.00
-100.00%
46.54
+0.00%
46.54
Stockholders Equity
22.36
+1108.66%
-2.22
+96.01%
-55.54
+11.94%
-63.07
Common Stock Equity
22.36
+1108.66%
-2.22
+96.01%
-55.54
+11.94%
-63.07
Capital Stock
0.41
+0.00%
0.41
+0.25%
0.41
+0.00%
0.41
Common Stock
0.41
+0.00%
0.41
+0.25%
0.41
+0.00%
0.41
Preferred Stock
0.00
0.00
0.00
—
Share Issued
4.57
+0.65%
4.54
+2.07%
4.45
+1.82%
4.37
Ordinary Shares Number
4.43
+0.44%
4.41
+1.33%
4.35
+1.27%
4.30
Treasury Shares Number
0.14
+8.02%
0.13
+35.71%
0.10
+35.04%
0.07
Additional Paid In Capital
234.83
+0.01%
234.81
+24.80%
188.15
+0.34%
187.52
Retained Earnings
-210.81
+10.44%
-235.38
+2.77%
-242.08
+2.78%
-249.02
Treasury Stock
2.07
+0.88%
2.05
+2.29%
2.01
+1.62%
1.98
Total Equity Gross Minority Interest
—
—
-55.54
—
Total Capitalization
22.36
+1108.66%
-2.22
+95.68%
-51.30
+1.18%
-51.91
Working Capital
4.80
+314.25%
1.16
+213.64%
-1.02
+52.14%
-2.13
Invested Capital
22.36
+978.73%
2.07
+104.49%
-46.20
+6.50%
-49.41
Total Debt
1.18
-79.80%
5.86
-47.68%
11.19
-30.45%
16.09
Net Debt
—
2.83
-51.60%
5.84
-33.86%
8.84
Capital Lease Obligations
1.18
-24.46%
1.57
-15.31%
1.85
-23.78%
2.43
Net Tangible Assets
22.36
+1108.66%
-2.22
+96.01%
-55.54
+13.13%
-63.93
Tangible Book Value
22.36
+1108.66%
-2.22
+96.01%
-55.54
+13.13%
-63.93
Interest Payable
—
—
—
0.00
Line Of Credit
—
—
0.00
-100.00%
2.50
Other Inventories
—
—
—
1.22
Preferred Stock Equity
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
5.83
+25.51%
4.65
+22.62%
3.79
+149.26%
-7.69
Cash Flow From Continuing Operating Activities
5.83
+25.48%
4.65
+22.62%
3.79
+149.26%
-7.69
Net Income From Continuing Operations
24.57
+266.68%
6.70
+242.99%
1.95
+108.90%
-21.96
Depreciation Amortization Depletion
0.82
+9.76%
0.75
-53.28%
1.60
-54.28%
3.50
Depreciation
0.82
+9.76%
0.75
-53.28%
1.60
-54.28%
3.50
Depreciation And Amortization
0.82
+9.76%
0.75
-53.28%
1.60
-54.28%
3.50
Other Non Cash Items
0.17
-70.91%
0.58
-30.75%
0.84
-26.85%
1.15
Stock Based Compensation
0.04
-87.97%
0.29
-53.81%
0.63
-51.69%
1.30
Provisionand Write Offof Assets
—
—
—
—
Asset Impairment Charge
0.20
—
0.00
-100.00%
12.40
Deferred Tax
-21.25
0.00
0.00
+100.00%
-0.09
Deferred Income Tax
-21.25
0.00
0.00
+100.00%
-0.09
Operating Gains Losses
—
—
—
—
Gain Loss On Investment Securities
—
—
—
—
Change In Working Capital
1.29
+135.01%
-3.68
-197.65%
-1.24
+69.06%
-3.99
Change In Receivables
2.90
+183.53%
-3.47
-1626.87%
0.23
+270.68%
-0.13
Changes In Account Receivables
2.90
+183.53%
-3.47
-1626.87%
0.23
+270.68%
-0.13
Change In Payables And Accrued Expense
-1.40
-2945.65%
-0.05
+96.36%
-1.26
+53.27%
-2.71
Change In Accrued Expense
-0.59
-257.83%
-0.17
+90.53%
-1.75
+11.02%
-1.97
Change In Payable
-0.81
-772.50%
0.12
-75.46%
0.49
+166.53%
-0.73
Change In Account Payable
-0.81
-772.50%
0.12
-75.46%
0.49
+166.53%
-0.73
Change In Other Current Assets
-0.23
-420.55%
0.07
+182.02%
-0.09
+51.10%
-0.18
Change In Other Current Liabilities
0.03
+111.39%
-0.24
-117.43%
-0.11
+88.77%
-0.97
Investing Cash Flow
-0.36
+59.36%
-0.88
-906.90%
-0.09
-101.40%
6.21
Cash Flow From Continuing Investing Activities
-0.36
+59.36%
-0.88
-906.90%
-0.09
-101.40%
6.21
Net PPE Purchase And Sale
-0.36
+59.36%
-0.88
-86.38%
-0.47
-45.96%
-0.32
Purchase Of PPE
-0.36
+59.36%
-0.88
-86.38%
-0.47
-45.96%
-0.32
Sale Of PPE
—
—
—
0.00
Capital Expenditure
-0.36
+59.36%
-0.88
-86.38%
-0.47
-45.96%
-0.32
Net Business Purchase And Sale
—
0.00
-100.00%
0.38
-94.13%
6.53
Gain Loss On Sale Of Business
—
—
—
—
Financing Cash Flow
-4.43
+23.70%
-5.81
-15.40%
-5.03
-267.73%
3.00
Cash Flow From Continuing Financing Activities
-4.43
+23.70%
-5.81
-15.40%
-5.03
-267.73%
3.00
Net Issuance Payments Of Debt
-4.40
+21.43%
-5.60
-124.00%
-2.50
-183.33%
3.00
Issuance Of Debt
—
—
0.00
-100.00%
3.00
Repayment Of Debt
-4.40
+21.43%
-5.60
-124.00%
-2.50
0.00
Long Term Debt Issuance
—
—
0.00
-100.00%
2.00
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
—
—
0.00
-100.00%
2.00
Short Term Debt Issuance
—
—
0.00
-100.00%
1.00
Short Term Debt Payments
-4.40
+21.43%
-5.60
-124.00%
-2.50
0.00
Net Short Term Debt Issuance
-4.40
+21.43%
-5.60
-124.00%
-2.50
-350.00%
1.00
Net Common Stock Issuance
—
—
0.00
-100.00%
0.11
Common Stock Payments
—
—
-0.03
+70.37%
-0.11
Repurchase Of Capital Stock
—
—
-0.03
+70.37%
-0.11
Proceeds From Stock Option Exercised
-0.02
+60.87%
-0.05
-43.75%
-0.03
+70.37%
-0.11
Net Other Financing Charges
-0.01
+91.93%
-0.16
+93.56%
-2.50
—
Changes In Cash
1.04
+151.25%
-2.04
-53.16%
-1.33
-187.85%
1.51
End Cash Position
2.50
+71.46%
1.46
-58.23%
3.50
-27.55%
4.83
Free Cash Flow
5.47
+45.23%
3.77
+13.59%
3.32
+141.42%
-8.01
Interest Paid Supplemental Data
0.17
-73.12%
0.62
-42.77%
1.09
+12.46%
0.97
Income Tax Paid Supplemental Data
0.10
+741.67%
0.01
-95.56%
0.27
+7.57%
0.25
Common Stock Issuance
—
—
0.00
-100.00%
0.11
Issuance Of Capital Stock
—
—
0.00
-100.00%
0.11
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
Sale Of Business
—
0.00
-100.00%
0.38
-94.13%
6.53
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category